Abstract:Previous genome-wide association studies have demonstrated that single nucleotide polymorphisms in T-box (TBX)5 are associated with increased susceptibility to atrial fibrillation (AF), and a recent study has causally linked a TBX5 mutation to atypical Holt-Oram syndrome and paroxysmal AF. However, the prevalence and spectrum of TBX5 mutations in patients with AF remain to be elucidated. In the present study, a cohort of 190 unrelated patients with idiopathic AF were prospectively recruited, with 400 unrelated healthy individuals recruited as controls. The coding exons and flanking introns of the TBX5 gene were sequenced in the participants. The functional characteristics of the mutant TBX5 were delineated in contrast with its wild-type counterpart using a dual-luciferase reporter assay system. As a result, a novel heterozygous TBX5 mutation, p.P132S, was identified in an index patient with AF, with a mutational prevalence of similar to 0.53%. Genetic analysis of the proband's family showed that the mutation co-segregated with AF, and was transmitted in an autosomal dominant pattern. The missense mutation was absent in the 800 control chromosomes, and the altered amino acid was completely evolutionarily conserved across species. Functional analyses revealed that the mutant TBX5 had significantly reduced transcriptional activity. Furthermore, the mutation markedly decreased the synergistic activation between TBX5 and NK2 homeobox 5, another transcription factor which has been causatively linked to AF. The present study was the first, to the best of our knowledge, to report on the association between a TBX5 loss-of-function mutation and increased susceptibility to AF. These results provide novel insight into the molecular mechanism underpinning AF, and have potential implications in the development of novel prophylactic and therapeutic strategies for AF, the most common form of sustained cardiac arrhythmia.

Nkx2-6 Mutation Predisposes To Familial Atrial Fibrillation

TBX5 Mutations Contribute to Early-Onset Atrial Fibrillation in Chinese and Caucasians.

A Novel NKX2.5 Loss-of-function Mutation Responsible for Familial Atrial Fibrillation.

KCNQ1 Gain-of-function Mutation in Familial Atrial Fibrillation

Identification of a KCNE2 Gain-of-Function Mutation in Patients with Familial Atrial Fibrillation

Mutational Spectrum of the NKX2-5 Gene in Patients with Lone Atrial Fibrillation

A Kir2.1 Gain-of-function Mutation Underlies Familial Atrial Fibrillation.

Prevalence and Spectrum of Nkx2.5 Mutations Associated with Idiopathic Atrial Fibrillation

Novel NKX2-5 Mutations in Patients With Familial Atrial Septal Defects

[Mutation of NKX2-5 Gene in Patients with Atrial Septal Defect].

KLF15 Loss-of-Function Mutation Underlying Atrial Fibrillation As Well As Ventricular Arrhythmias and Cardiomyopathy

A SHOX2 Loss-of-function Mutation Underlying Familial Atrial Fibrillation

[Identification and Functional Analysis of a KCNA5 Mutation Responsible for Idiopathic Atrial Fibrillation].

A Novel NKX2-5 Mutation in Familial Ventricular Septal Defect.

A KCNQ1 Mutation Causes a High Penetrance for Familial Atrial Fibrillation

Abstract 19018: Unraveling the Regulatory Landscape of NKX2-5 in Human Left Atrial Tissue: Implications for Atrial Fibrillation

SNX17 (sorting Nexin 17) Mediates Atrial Fibrillation Onset Through Endocytic Trafficking of the Kv1.5 (potassium Voltage-Gated Channel Subfamily A Member 5) Channel

Prevalence and Spectrum of NKX2.5 Mutations in Patients with Congenital Atrial Septal Defect and Atrioventricular Block.

PRRX1 Loss‐of‐Function Mutations Underlying Familial Atrial Fibrillation

TBX5 loss-of-function mutation contributes to atrial fibrillation and atypical Holt-Oram syndrome

Association of NKX2-5 Gene with Congenital Heart Disease